Iterum offering $8.4 million units, including 6.5% exchangeables

By Wendy Van Sickle

Columbus, Ohio, Aug. 6 – Iterum Therapeutics plc registered to sell up to $8.4 million of units, each consisting of one 6.5% exchange senior subordinated note due 2025 and 50 limited recourse royalty-linked subordinated notes to be issued by Iterum Therapeutics Bermuda Ltd., according to a filing with the Securities and Exchange Commission.

The subscription period will run from 5 p.m. ET on Aug. 11 through 5 p.m. ET on Aug. 31.

The exchangeable notes will be issued as additional notes under an indenture dated Jan. 21, 2020 under which the company previously issued $51.6 million of the exchangeable notes in a private placement.

Georgeson LLC is the information agent.

The clinical-stage pharmaceutical company is based in Ireland.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.